The Society of Interventional Radiology has released new practice guidance for the use of prostatic artery embolization to treat enlarged prostate, a condition that affects many men worldwide. This guidance is a significant development in the field of men's health, particularly for those suffering from benign prostatic hyperplasia, also known as BPH.
The new practice guidance has been published in the Journal of Vascular and Interventional Radiology, a leading medical journal that showcases the latest research and advancements in the field of vascular and interventional radiology. The timing of the publication coincides with the start of Men's Health Month in June, a month-long awareness campaign that aims to promote men's health and wellbeing.
Prostatic artery embolization is a minimally invasive procedure that has shown promising results in treating enlarged prostate. The procedure involves blocking the blood supply to the prostate gland, which helps to reduce its size and alleviate symptoms associated with BPH. The new practice guidance provides healthcare professionals with a comprehensive framework for the use of PAE in treating enlarged prostate, including patient selection, procedure protocols, and follow-up care.
The publication of the new practice guidance is expected to have a positive impact on men's health outcomes, particularly for those who have been diagnosed with BPH. By providing healthcare professionals with the latest guidance and recommendations, the Society of Interventional Radiology aims to improve the quality of care and treatment options available to men suffering from this condition. As Men's Health Month gets underway, the new practice guidance serves as a timely reminder of the importance of prioritizing men's health and wellbeing.
